Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Sildenafil in postprostatectomy erectile dysfunction (perspective)

Research output: Contribution to journalReviewResearchpeer-review

  1. Current guideline recommendations and analysis of evidence quality on low-intensity shockwave therapy for erectile dysfunction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction

    Research output: Contribution to journalReviewResearchpeer-review

  3. Is low-intensity shockwave therapy for erectile dysfunction ready for clinical practice?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Current guideline recommendations and analysis of evidence quality on low-intensity shockwave therapy for erectile dysfunction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction

    Research output: Contribution to journalReviewResearchpeer-review

  3. Hormone naïve metastatic prostate cancer: How to treat it?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Successful extraction of sperm cells after autologous bone marrow transplant: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. An innovative nurse-led cystoscopy clinic in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Erectile dysfunction (ED) is a common side effect to radical prostatectomies, even with nerve-sparing procedures. To ameliorate the problem so-called "penile rehabilitation" programs have been developed. The most widely used method of this is subscribing sildenafil or other PDE5-inhibitors to patients following surgery. This is based on a theory that these drugs may increase penile oxygenation and provide antiapoptotic factors (primarily NO and cGMP), thus protecting the penile tissue in a period with reduced nerve function following the surgery. Preclinical studies have confirmed the potential of sildenafil in this context and early human trials have suggested that a steady ingestion of sildenafil might protect the structural integrity of the penis. However, subsequent well-designed trials have not been able to confirm the initial findings. This fits well with sildenafil's mechanism of action because it does not actually induce erections or the production of either nitric oxide or cGMP. Rather, the drug enhances effects of an erectile response induced by neurotransmitters from the cavernous nerves. Therefore, sildenafil should no longer be offered as a sole means of penile rehabilitation. Rather, more research is needed, and clinicians need to apply a broader concept of sexual rehabilitation in postprostatectomy ED.

Original languageEnglish
JournalInternational Journal of Impotence Research
Volume31
Issue number2
Pages (from-to)61-64
Number of pages4
ISSN0955-9930
DOIs
Publication statusPublished - Mar 2019

ID: 56782455